Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes
- 1 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (5), 1086-1093
- https://doi.org/10.1161/01.atv.0000215951.36219.a4
Abstract
Objective— The mechanisms responsible for the increased cardiovascular disease risk that accompanies type 2 diabetes (T2D) remain poorly understood. It is commonly held that endothelial dysfunction and low-grade inflammation can explain, at least in part, why deteriorating glucose tolerance is associated with cardiovascular disease. However, there is no direct evidence for this contention. Methods and Results— In this population-based study (n=631), T2D was cross-sectionally associated with both endothelial dysfunction and low-grade inflammation, whereas impaired glucose metabolism (IGM) was associated only with low-grade inflammation. These findings were independent of other risk factors that accompany T2D or IGM. During a follow-up of 11.7 years (median; range 0.5 to 13.2 years), low-grade inflammation was associated with a greater risk of cardiovascular mortality (hazard ratio, 1.43 [95% CI, 1.17 to 1.77] per 1 SD difference). For endothelial dysfunction, the association with cardiovascular mortality w... Endothelial dysfunction and low-grade inflammation may explain, at least in part, the increased cardiovascular disease risk in type 2 diabetes (T2D). For endothelial dysfunction, the association with cardiovascular mortality was stronger in diabetic than in nondiabetic individuals (P interaction=0.06). T2D-associated endothelial dysfunction and low-grade inflammation explained ≈43% of the increase in cardiovascular mortality risk conferred by T2D.Keywords
This publication has 41 references indexed in Scilit:
- Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is notAtherosclerosis, 2004
- Fasting Plasma Leptin, Tumor Necrosis Factor-α Receptor 2, and Monocyte Chemoattracting Protein 1 Concentration in a Population of Glucose-Tolerant and Glucose-Intolerant WomenDiabetes Care, 2003
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002
- Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn StudyKidney International, 2002
- Tissue Factor Pathway Inhibitor and Other Endothelium-Dependent Hemostatic Factors in Elderly Individuals With Normal or Impaired Glucose Tolerance and Type 2 DiabetesDiabetes Care, 2002
- Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?European Journal of Clinical Investigation, 2002
- Subclinical States of Glucose Intolerance and Risk of Death in the U.S.Diabetes Care, 2001
- Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.Diabetes Care, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Diabetes and atherosclerosis: An epidemiologic viewDiabetes/Metabolism Research and Reviews, 1987